(NASDAQ:HCWB), First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 — cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind immunotherapeutic for autoimmune and pro-inflammatory diseases MIRAMAR, Fla., Nov. 18, 2025 […]

LONDON, UK / ACCESS Newswire / November 18, 2025 / Ecora (LSE:ECOR)(TSX:ECOR)(OTCQX:ECRAF) ("Ecora" or the "Company") has received notification of the following transaction by CH Invest GmbH, a Person Closely Associated ("PCA") with Ms. Christine Coignard, Non-Executive Director of Ecora. On 14 November 2025, CH Invest GmbH acquired 11,400 ordinary shares of 2 pence each

Selection underscores QuickLogic's ability to deliver flexible, silicon-proven IP that reduces ASIC risk and shortens design cycles for commercial applications QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP and ruggedized FPGAs, announced today that its eFPGA Hard IP was selected by Chipus for a high performance data center production ASIC that

With early access for select partners and customers, Analysis Agent is just one part of Solver's AI-first initiative Solver, an AI-accelerated xFP&A software company, has released its Analysis Agent, advancing the company's AI-first initiative powered by Solver Copilotto drive innovation across the Solver solution. Originally announced summer 2025, the AI-first initiativeempowers key stakeholders in various

Fraud and forgery claims tied to refinance transactions have risen considerably in recent years, representing over 40% of all title insurer losses and expenses, according to a new study released today by global consulting and actuarial firm Milliman Inc. The study,commissioned by the American Land Title Association (ALTA), also shows that the average cost for

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

Allied and RioCan Provide Office Leasing Update for The Well GlobeNewswire November 18, 2025 TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX: “AP.UN”) and RioCan Real Estate Investment Trust (“RioCan”) (TSX: “REI.UN”) today provided an office leasing update for The Well in Toronto. A Canadian company has agreed

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease GlobeNewswire November 18, 2025 First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 — cytokine that maintains proper numbers and functions of regulatory T cells to control excessive

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Integer Holdings Corporation ("Integer Holdings Corporation") (NYSE:ITGR) concerning possible violations of federal securities laws. On October 23, 2025, Integer reported its third quarter fiscal 2025 results "in line with [their] expectations," but

Nordic Capital today announced an agreement to become the majority owner in Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. The investment, leveraging Nordic Capital's experience as a leading investor in healthcare and life science for over 30 years, will be made in close collaboration with Evosep's founders and